中国学者近期发表的论文
1.	NF1 regulates apoptosis in ovarian cancer cells by targeting MCL1 via miR-142-5p. Author: Su J1, Ruan S1, Dai S1, Mi J1, Chen W2, Jiang S1. Journal: Pharmacogenomics. 2019 Feb;20(3):155-165. doi: 10.2217/pgs-2018-0161. Epub 2018 Dec 13.    PubMed      DOI
2.	Cost-effectiveness analysis of UGT1A1*6/*28 genotyping for preventing FOLFIRI-induced severe neutropenia in Chinese colorectal cancer patients. Author: Wei X1, Cai J1, Sun H1, Li N2, Xu C2, Zhang G3, Sui Y1, Zhuang J1, Zheng B2,4. Journal: Pharmacogenomics. 2019 Mar;20(4):241-249. doi: 10.2217/pgs-2018-0138. Epub 2019 Jan 10.    PubMed      DOI
3.	Association between genetic polymorphisms and angiotensin-converting enzyme inhibitor-induced cough: a systematic review and meta-analysis. Author: Mu G1, Xiang Q1, Zhou S1, Xie Q1, Liu Z1, Zhang Z1, Cui Y1. Journal: Pharmacogenomics. 2019 Feb;20(3):189-212. doi: 10.2217/pgs-2018-0157. Epub 2019 Jan 23.    PubMed      DOI
4.	Polymorphisms in IGF2/H19 gene locus are associated with platinum-based chemotherapeutic response in Chinese patients with epithelial ovarian cancer. Author: Zeng Y1,2, Li TL3, Zhang HB1,2, Deng JL1,2, Zhang R4, Sun H5, Wan ZR6, Liu YZ1,2, Zhu YS7, Wang G1,2. Journal: Pharmacogenomics. 2019 Feb;20(3):179-188. doi: 10.2217/pgs-2018-0153. Epub 2019 Jan 23.    PubMed      DOI
5.	Prediction of tacrolimus dosage in the early period after heart transplantation: a population pharmacokinetic approach. Author: Han Y1, Zhou H1, Cai J2, Huang J3, Zhang J2, Shi SJ1, Liu YN1, Zhang Y1. Journal: Pharmacogenomics. 2019 Jan;20(1):21-35. doi: 10.2217/pgs-2018-0116. Epub 2018 Dec 6.    PubMed      DOI
6.	Population pharmacokinetic and pharmacogenetics of imatinib in Chinese patients with chronic myeloid leukemia. Author: Wang Q1,2, Jiang ZP3, Yu EQ4,5, Zeng J6, Zhu Y1,2, Cai HL1,2, Yan M1,2, Xiang DX1,2, Zhao XL3, Xu P1,2, Jiao Z4, Banh HL1,2,7. Journal: Pharmacogenomics. 2019 Mar;20(4):251-260. doi: 10.2217/pgs-2018-0139. Epub 2019 Feb 15.    PubMed      DOI
7.	Evaluation of the predictive performance of Bayesian dosing for warfarin in Chinese patients. Author: Dong J1, Shi GH1, Lu M1, Huang S2, Liu YH1, Yao JC1, Li WY1, Li LX2. Journal: Pharmacogenomics. 2019 Feb;20(3):167-177. doi: 10.2217/pgs-2018-0127. Epub 2019 Feb 19.    PubMed      DOI
8.	The interleukin-17 G-197A polymorphism is associated with cyclosporine metabolism and transplant rejection in liver transplant recipients. Author: Sun B1,2, Gao J1, Shi W1, Guo Y1, Fan J3, Zhang J1, Li X4, Liu G1. Journal: Pharmacogenomics. 2019 Apr;20(6):447-456. doi: 10.2217/pgs-2018-0198. Epub 2019 Feb 25.    PubMed      DOI
9.	Differential long noncoding RNAs expression in cancer-associated fibroblasts of non-small-cell lung cancer. Author: Teng C1, Huang G1, Luo Y1, Pan Y1, Wang H2, Liao X3, Li Y3, Yang J1. Journal: Pharmacogenomics. 2019 Feb;20(3):143-153. doi: 10.2217/pgs-2018-0102. Epub 2019 Feb 27.    PubMed      DOI
10.	GLP1R variant is associated with response to exenatide in overweight Chinese Type 2 diabetes patients. Author: Yu M1, Wang K1, Liu H2, Cao R3. Journal: Pharmacogenomics. 2019 Mar;20(4):273-277. doi: 10.2217/pgs-2018-0159. Epub 2019 Mar 18.    PubMed      DOI

同类著名期刊名称 h-index CiteScore PHARMACOLOGICAL REVIEWS 210 18.73 ADVANCED DRUG DELIVERY REVIEWS 278 13.90 DRUG RESISTANCE UPDATES 100 13.15 TRENDS IN PHARMACOLOGICAL SCIENCES 201 9.98 MEDICINAL RESEARCH REVIEWS 119 8.83 PHARMACOLOGY & THERAPEUTICS 180 10.16 DRUG DISCOVERY TODAY 157 7.08 BRITISH JOURNAL OF PHARMACOLOGY 190 6.12 CLINICAL PHARMACOLOGY & THERAPEUTICS 173 4.47 PHARMACOLOGICAL RESEARCH 118 5.27

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 232161 CANCER RESEARCH 145292 International Journal of Nanomedicine 143494 Molecular Medicine Reports 141865 CANCER LETTERS 139206 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 115878 JOURNAL OF ETHNOPHARMACOLOGY 115329 JOURNAL OF MEDICINAL CHEMISTRY 114495 International Journal of Environmental Research and Public Health 111362 Theranostics 110872